Comparison of Alectinib/Crizotinib Data in First-Line Therapy in Patients with Anaplastic LymphomakinasePositive Nonsmall Cell Lung Carcinoma with Poor Prognostic Features for Alectinib
Turk Thorac J 2023;24(4):180-185
1. Department of Pulmonology, Dr. Suat Seren Chest Diseases and Surgery Training and Research Hospital, İzmir, Turkey
2. Department of Medical Oncology, Bakırçay University, İzmir, Turkey
3. Department of Medical Oncology, Ege University, İzmir, Turkey
4. Department of Nuclear Medicine, Dr. Suat Seren Chest Diseases and Surgery Training and Research Hospital, İzmir, Turkey
Bilgi mevcut değil.
Bilgi mevcut değil
Kabul Tarihi: 01.07.2023
Online Tarih: 01.07.2023
Yayın Tarihi: 01.07.2023
2024 ©️ Galenos Publishing House